OXIDANTS, ENERGY AND PULMONARY VASCULAR DEVELOPMENT
氧化剂、能量和肺血管发育
基本信息
- 批准号:6110795
- 负责人:
- 金额:$ 28.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-12-01 至 1999-11-30
- 项目状态:已结题
- 来源:
- 关键词:aconitate hydratase bioenergetics bronchopulmonary dysplasia cell growth regulation embryo /fetus tissue /cell culture enzyme activity enzyme induction /repression free radical scavengers hyperoxia iron sulfur protein laboratory rat lung injury newborn animals nitric oxide oxidative stress oxygen tension pulmonary artery pulmonary hypertension respiratory distress syndrome of newborn thioredoxin vascular endothelium
项目摘要
(Adapted from the application's abstract) Impaired energy metabolism due
to hyperoxic exposure may have important negative consequences for lung
growth, development and function in the newborn such as the poorly
developed, scarred lungs of bronchopulmonary dysplasia. The possibility
that energy metabolism is seriously inhibited by normobaric hyperoxia has
been an issue of considerable controversy. However, the recent
identification of the critical tricarboxylic acid cycle enzyme aconitase
as a target which is rapidly and potently inhibited by hyperoxia provides
one example of such an impairment which may have devastating effects on
lung growth and function. It is hypothesized that inactivation of the
critical tricarboxylic acid cycle enzyme aconitase by hyperoxia is a key
event which inhibits energy (ATP) production, and , consequently, lung
cell growth and function in the premature newborn. Nitric oxide also could
play a contributory role in this process. Further, it is proposed that
this process may be exaggerated in the premature due to a deficiency of
important lung antioxidant defenses. In addition, it is suggested that
interventions which either inhibit aconitase inactivation or potentiate
its re-activation or which facilitate energy production through its
alternative mechanism, will restore lung cell growth and function. To test
these hypothesis, alveolar epithelial cells from late gestation fetal rat
grown on matrix, and, in some studies, co-cultured in the presence of
living matrix cells on floating filters, or fetal lung explants, will be
utilized.
The effects of inhibition of aconitase both by hyperoxia and by the potent
specific inhibitor fluorocitrate on energy production, growth, cell work
such as surfactant protein expression and lipid production, and expression
of epithelium-derived growth factors critical in pulmonary vascular
development such as vascular endothelial growth factor (VEGF) all will be
assessed. Nuclear magnetic resonance and other analytical biochemical
techniques will be used to make real-time determinations of energy and
intermediary metabolites during ongoing exposure to hyperoxia or
flurocitrate. In bovine fetal pulmonary vascular endothelial cells, the
effect of aconitase inhibition on cell energy status, growth, and growth-
related function (expression of VEGF receptors) will be assessed. Further,
the sensitivity of other cell types of the vascular wall, smooth muscle
and fibroblast, to energy impairment and growth inhibition due to
aconitase inhibition will be compared. Based on these studies, antioxidant
interventions which may decrease aconitase inactivation by hyperoxia, or
increase it re-activation, will be evaluated for potential palliative
effects. Through novel approaches, these studies will provide new
information about the mechanisms by which hyperoxia impairs energy
metabolism in the lung and alters pulmonary vascular growth and
development.
In addition, palliative therapies could be developed as a result.
(改编自申请摘要)能量代谢受损
高氧暴露可能对肺部产生重要的负面后果
生长发育与功能不佳等新生儿
支气管肺发育不良的发达、伤痕累累的肺。这种可能性
常压高氧严重抑制了能量代谢
一直是一个颇具争议的问题。然而,最近的
三元酸循环关键酶乌头酸酶的鉴定
作为一个被高氧迅速而有效地抑制的靶点,提供了
这种损害的一个例子可能会对
肺的生长和功能。它假设失活的
关键的三元酸循环酶乌头酸酶是高氧的关键
抑制能量(ATP)产生的事件,从而抑制肺
早产儿的细胞生长和功能。一氧化氮也可能
在这一进程中发挥贡献作用。此外,还提议
这个过程在早产儿中可能被夸大了,因为缺乏
重要的肺部抗氧化剂防御。此外,还建议
抑制乌头酸酶失活或增强其活性的干预
它的重新激活或通过其促进能量生产
替代机制,将恢复肺细胞的生长和功能。为了测试
这些假说,孕晚期胎鼠肺泡上皮细胞
在基质上生长,在一些研究中,在存在的情况下共培养
漂浮过滤器上的活基质细胞,或胎儿肺外植体,将
被利用了。
高氧和强效氧对乌头酸酶的抑制作用
特异性抑制剂氟柠檬酸对能量产生、生长、细胞工作的影响
如表面活性物质蛋白表达和脂肪产生,以及表达
上皮源性生长因子在肺血管中的关键作用
如血管内皮生长因子(VEGF)等的开发都将
评估过了。核磁共振及其他分析生化
将使用技术来实时确定能源和
持续暴露在高氧或其他环境中的中间代谢产物
氟氯硝酸盐。在牛胎肺血管内皮细胞中,
乌头酸酶抑制对细胞能量状态、生长和生长的影响
相关功能(血管内皮生长因子受体的表达)将被评估。此外,
血管壁、平滑肌等其他细胞类型的敏感性
和成纤维细胞,由于能量损伤和生长抑制
将乌头酸酶的抑制率进行比较。基于这些研究,抗氧化剂
可降低因高氧而使乌头酸酶失活的干预措施,或
增加它的重新激活,将被评估为潜在的姑息性
效果。通过新的方法,这些研究将提供新的
关于高氧损害能量的机制的信息
肺内的代谢,改变肺血管的生长和
发展。
此外,姑息疗法也可能因此被开发出来。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARL W WHITE其他文献
CARL W WHITE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARL W WHITE', 18)}}的其他基金
OXIDANTS, ENERGY AND PULMONARY VASCULAR DEVELOPMENT
氧化剂、能量和肺血管发育
- 批准号:
6565054 - 财政年份:2001
- 资助金额:
$ 28.49万 - 项目类别:
OXIDANTS, ENERGY AND PULMONARY VASCULAR DEVELOPMENT
氧化剂、能量和肺血管发育
- 批准号:
6410581 - 财政年份:2000
- 资助金额:
$ 28.49万 - 项目类别:
OXIDANTS, ENERGY AND PULMONARY VASCULAR DEVELOPMENT
氧化剂、能量和肺血管发育
- 批准号:
6302487 - 财政年份:1999
- 资助金额:
$ 28.49万 - 项目类别:
OXIDANTS, ENERGY AND PULMONARY VASCULAR DEVELOPMENT
氧化剂、能量和肺血管发育
- 批准号:
6273251 - 财政年份:1997
- 资助金额:
$ 28.49万 - 项目类别:
OXIDANTS, ENERGY AND PULMONARY VASCULAR DEVELOPMENT
氧化剂、能量和肺血管发育
- 批准号:
6242789 - 财政年份:1996
- 资助金额:
$ 28.49万 - 项目类别:
NEURAL CONTROL OF THE CORONARY CIRCULATION IN HUMANS
人类冠状动脉循环的神经控制
- 批准号:
3509923 - 财政年份:1991
- 资助金额:
$ 28.49万 - 项目类别:
NEURAL CONTROL OF THE CORONARY CIRCULATION IN HUMANS
人类冠状动脉循环的神经控制
- 批准号:
3355850 - 财政年份:1987
- 资助金额:
$ 28.49万 - 项目类别:
NEURAL CONTROL OF THE CORONARY CIRCULATION IN HUMANS
人类冠状动脉循环的神经控制
- 批准号:
3355845 - 财政年份:1987
- 资助金额:
$ 28.49万 - 项目类别:
ANTIOXIDANT DEFENSE MECHANISM IN VASCULAR INJURY OF THE NEWBORN
新生儿血管损伤的抗氧化防御机制
- 批准号:
3780953 - 财政年份:
- 资助金额:
$ 28.49万 - 项目类别:
EAR OXIMETRY IN MONITORING OF CRITICALLY ILL CHILDREN
耳氧饱和度监测危重儿童
- 批准号:
3972470 - 财政年份:
- 资助金额:
$ 28.49万 - 项目类别:
相似海外基金
Control of epithelial morphology and bioenergetics by Toll receptors during dynamic tissue remodeling
动态组织重塑过程中 Toll 受体对上皮形态和生物能的控制
- 批准号:
10737093 - 财政年份:2023
- 资助金额:
$ 28.49万 - 项目类别:
Mitochondria-rich microvesicles for restoration of intracellular bioenergetics
富含线粒体的微泡用于恢复细胞内生物能
- 批准号:
10586699 - 财政年份:2023
- 资助金额:
$ 28.49万 - 项目类别:
Defining the mechanisms of MSC extracellular vesicle modulation of microglia metabolism and bioenergetics in traumatic brain injury recovery
定义MSC细胞外囊泡调节小胶质细胞代谢和生物能学在创伤性脑损伤恢复中的机制
- 批准号:
10719905 - 财政年份:2023
- 资助金额:
$ 28.49万 - 项目类别:
Characterizing Alzheimer's Risk in Retired Night Shift Workers: Cognitive Function, Brain Volume, and Brain Bioenergetics
退休夜班工人患阿尔茨海默病的风险特征:认知功能、脑容量和脑生物能学
- 批准号:
10350125 - 财政年份:2022
- 资助金额:
$ 28.49万 - 项目类别:
To everything a season: bioenergetics in seasonal environments
季节的一切:季节性环境中的生物能学
- 批准号:
RGPIN-2020-06705 - 财政年份:2022
- 资助金额:
$ 28.49万 - 项目类别:
Discovery Grants Program - Individual
The role of transcription factor Ying-Yang 1 in the cardiac bioenergetics regulation
转录因子Ying-Yang 1在心脏生物能调节中的作用
- 批准号:
10688160 - 财政年份:2022
- 资助金额:
$ 28.49万 - 项目类别:
Modulating Cellular Bioenergetics to Improve Skeletal Health
调节细胞生物能量以改善骨骼健康
- 批准号:
10661806 - 财政年份:2022
- 资助金额:
$ 28.49万 - 项目类别:
Unraveling the Associations of Molecular-Genetic Bioenergetics and Chemotherapy-Induced Fatigue Symptoms in Patients with Breast Cancer
揭示乳腺癌患者分子遗传学生物能学与化疗引起的疲劳症状之间的关联
- 批准号:
10684326 - 财政年份:2022
- 资助金额:
$ 28.49万 - 项目类别:
Mitochondrial protein S-glutathionylation: an in-depth interrogation of the glutaredoxin-2 glutathionylome and its impact on bioenergetics and redox signaling
线粒体蛋白 S-谷胱甘肽化:对 glutaredoxin-2 谷胱甘肽组的深入研究及其对生物能学和氧化还原信号传导的影响
- 批准号:
RGPIN-2022-03240 - 财政年份:2022
- 资助金额:
$ 28.49万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




